This Week’s Small-Cap Healthcare Roundup
Insights - Tekmira Pharmaceuticals (TKMR) was the momentum stock of the week as the spread of Ebola continues in Guinea, Liberia and Sierra Leone, and two infected Americans … Continue Reading
Read nowAuthor Archives: Editorial Staff
Arena Pops then Drops Following Earnings Beat
Insights - Arena Pharmaceuticals (ARNA) reported a surprising earnings beat and profit in its second quarter, with EPS of $0.03, $0.14 better than Wall Street analysts who called for a … Continue Reading
Read now
KaloBios Moves Ahead with Phase II as Sanofi Kills Collaboration
Insights - KaloBios Pharmaceuticals (KBIO) slid 16% to $1.61 in after hours trading on the news that Sanofi Pasteur, the vaccines division of French pharma giant Sanofi, … Continue Reading
Read nowBiopharma Earnings are Under Way; Our Top Stories this Past Week
Insights - The story of the week was Puma Biotechnology’s (PBYI) unexpected success in the phase 3 ExteNET trial, which sent the stock soaring 200% in after hours trading on Tuesday … Continue Reading
Read now
Puma’s Stock Just Ripped Through the Roof
Insights - Puma Biotechnology (PUMA) shares ripped higher by 200% in after-hours trading on Tuesday with positive results from a late-stage trial of Puma’s experimental breast cancer drug, neratinib. The ExteNET … Continue Reading
Read now
With Sandoz Deal, Anacor Investors Get a Little More Comfortable
Insights - With Sandoz deal, Anacor (ANAC) investors can get a little more comfortable with the upcoming commercial launch.
Read nowThe Fed is Scrutinizing Biotech Stocks; You Should Too
Recap - In the three trading sessions following the Fed’s semi-annual monetary policy report, in which the fed specifically called out small biotech equities as overvalued, the iShares … Continue Reading
Read now